Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

Optibiotix signs 'very good' manufacturing deal with Tata Chemicals

Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI) tells Proactive's Andrew Scott they've signed a manufacturing agreement with India-listed food ingredients giant Tata Chemicals.

It is an expansion of a deal the two inked last December and gives Tata, part of the Tata Group, the exclusive rights to produce a sugar from OptiBiotix’s LP-LDL probiotic strain.

 
Meet ImmuPharma PLC, Synairgen plc, Tissue Regenix Group PLC, Tissue Regenix Group PLC and WideCells Group at our event, London, 02 November 2017. Register here »
View full OPTI profile View Profile

OptiBiotix Health plc Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use